NEW – SARS-CoV-2 IgG & IgM ELISA Kits
The recent and rapid spread of the novel coronavirus, SARS-CoV-2, has called for the development of new assays to detect the presence of this virus in patient samples or evidence of recent infection. At Bethyl, our strategy has been to develop high-quality assays to detect the presence of anti-SARS-CoV-2 antibodies in patient sera to accelerate discovery that improves lives. Let’s work together.
Our kits provide for an indirect ELISA, in which a recombinant receptor binding domain (RBD) of the Spike1 protein of SARS-CoV-2, where this protein has been hypothesized as one of the most immunogenic of its proteins, making it a good candidate for detecting immune response
Discover the Science Behind Bethyl's New ELISAs For Detecting COVID-19 Seroconverison.
The enzyme linked immunosorbent assays (ELISA) are for the detection of Human IgG or IgM antibodies specific for SARS-CoV-2 virus, specifically the RBD protein, in serum or plasma. These kits contain sufficient components to detect these antibodies in up to 45 samples, if tested in duplicate. It is intended to aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
Join our mailing list to receive the latest news and updates from our team.
Not Exactly What You Are Looking For?
Bulk Antibody Production to Support COVID-19 Research
We are a leading, trusted partner across labs globally for bulk anti-Human IgG, IgM & IgA antibodies to support COVID-19 (SARS-CoV-2) seroconversion assay development.
We Make Every Antibody We Sell.
Bethyl is dedicated to delivering the highest standards of product and service quality. Recognizing that your research and time are valuable, we promise to stand behind our products. Every Bethyl product ships with a 100% guarantee; choose Bethyl antibodies with confidence.
Bethyl Laboratories, Inc. • P.O. Box 850 • Montgomery, TX 77356
1-800-338-9579 • Fax: 1-866-597-6105
© 2021 - Bethyl Laboratories, Inc. All rights reserved.